Antimicrobial and antiinflammatory treatment of Bacterial meningitis

X. Saez-Llorens, Jr McCracken G.H.

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Mortality and morbidity rates of bacterial meningitis are still unacceptably high, and thus, new, potent antimicrobial agents and adjuvant anti-inflammatory strategies are being evaluated to improve patient outcome. With the declining rates of Haemophilus influenzae type B infections, after the introduction of conjugated vaccines, research to find preventive measures for Streptococcus pneumoniae and Neisseria meningitidis infections is underway. In the meantime, scientific effort is being directed optimally to treat disease caused by multiresistant pneumococcal strains.

Original languageEnglish (US)
Pages (from-to)619-636
Number of pages18
JournalInfectious disease clinics of North America
Issue number3
StatePublished - 1999

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Antimicrobial and antiinflammatory treatment of Bacterial meningitis'. Together they form a unique fingerprint.

Cite this